healthcare
USA

NeoChord, Inc., a St. Louis Park, Minn.-based medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, secured approx. $7m in additional funding as an extension of its Series D equity financing which was announced in November of 2018.